Home
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Andrew Renison
Andrew Renison
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Recent Developments In Patent Law: Non-Obviousness Of Pharmaceutical Formulations
04 Sep 2019 | United States
Expert Opinions On Reasonable Royalties Must Have A Basis For Comparison To Licenses On Which They Rely And Tie Them To The Facts Of The Case
01 Apr 2019 | United States
Supreme Court Restricts Where Patent Owners May Sue For Patent Infringement
28 Jun 2017 | United States
Court Dismisses Divided Infringement Claim Because Customer's Data Entry Steps Were Not Attributable To The Defendant Software Vendor
21 Dec 2016 | United States
A Prior Agreement To Outsource Manufacturing Does Not Invalidate A Patent
16 Sep 2016 | United States
Patent Damages May Not Include Value Of A Standard And Need Not Be Based On Smallest Salable Unit
19 Apr 2016 | United States
Court Refuses To Summarily Dismiss Patent-Infringement Claims Where Questions Exist As To Whether Some Or All Of A License Agreement Remains In Effect
01 Mar 2016 | United States
U.S. Supreme Court Upholds Ban On Post-Expiration Royalties In Patent Licenses
19 Aug 2015 | United States
Licensee May Challenge Patent Validity And Infringement In Royalty Dispute When Royalties Are Tied To The Practice Of The Licensed Patents
17 Jun 2015 | United States
In The Absence Of Supreme Court Consensus, Personal Jurisdiction Premised On A Stream-Of-Commerce Theory Is Assessed On A Case-By-Case Basis
26 Sep 2012 | United States
< 1 >
Contact Details
Washington, DC
Email Website
901 New York Avenue, NW
Washington, DC
United States
Telephone: 1-202-4084000

  © Mondaq® Ltd 1994 - 2021. All Rights Reserved.